502 Bad Gateway

Server Error


Bad Gateway

Web server received an invalid response while acting as a gateway or proxy server.

That's what you can do

Tracking treatments and results to decrease cancer rates

We are committed to understanding the causes of cancers, learning how to reduce cancer risk and identifying the most successful treatments. The Howard B. Hunt Tumor Registry, the first in Nebraska, tracks information about each cancer case, treatment and outcome in order to improve survivorship and decrease cancer rates. 

Dr. Hunt, a radiologist, began collecting information about each individual cancer case in 1927 when cancer claimed the lives of 95,000 Americans. He established the state's first tumor registry at Methodist Hospital. The registry, later named in his honor, has been tracking cancers ever since. 

The tumor registry has a 96% follow-up rate to help identify treatments and compare the quality of our care against local and national trends. Tumor registries catalog information about each case, always shielding any personally-identifying information. By analyzing this data, we are able to help determine risk factors, cancer causes and genetic or environmental contributors. This analysis helps determine treatment options and preventative measures.

CDC’s National Program of Cancer Registries (NPCR), and some state and city cancer registries send information to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. 

Committed to improving cancer prevention, diagnosis and care

Methodist Hospital's Tumor Registry is accredited by the North American Association of Centralized Cancer Registries at the Gold level. 

This accreditation indicates that we achieved the highest NAACCR standard for complete, accurate, and timely data to calculate standard incidence statistics for the year reviewed.

Howard B. Hunt Tumor Registry 
8601 W. Dodge Road, Suite 246
Omaha, NE 68114

(402) 354-3395


Methodist Cancer patients enjoy some of the highest participation rates in the nation for clinical trials and experimental treatments. Learn about the clinical trials available.